Deqsiga

<p>Deqsiga is a medicine used to treat people who:</p><ul><li>are at risk of infection because they lack a type of antibody called immunoglobulin G (IgG), which is a protein in the blood that helps the body fight infections. Deqsiga is used in people who are born with a lack of IgG (primary immunodeficiency syndrome, PID) and those who developed a lack of IgG after birth (secondary immunodeficiency syndrome, SID) and have infections that are severe or keep coming back, and for which medicines used to treat infections do not work;</li><li>have certain immune diseases (caused by the body’s own defence system attacking normal tissues), to help the activity of the immune system (immunomodulation). Deqsiga is used in patients with:<ul><li>primary immune thrombocytopenia (ITP), a disease associated with a lack of platelets (components in the blood that help it to clot) which puts patients at risk of bleeding;</li><li>Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy, inflammatory disorders of the nerves that result in muscle weakness and numbness;</li><li>Kawasaki disease, a disease mainly seen in children which causes inflammation of blood vessels;</li><li>multifocal motor neuropathy, nerve damage which causes weakness of the arms and legs.</li></ul></li></ul><p>Deqsiga contains the active substance human normal immunoglobulin.</p>